Shufro Rose & Co’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-12,941
| Closed | -$9.32K | – | 347 |
|
2022
Q4 | $9.32K | Hold |
12,941
| – | – | ﹤0.01% | 336 |
|
2022
Q3 | $16K | Hold |
12,941
| – | – | ﹤0.01% | 329 |
|
2022
Q2 | $15K | Hold |
12,941
| – | – | ﹤0.01% | 317 |
|
2022
Q1 | $28K | Hold |
12,941
| – | – | ﹤0.01% | 328 |
|
2021
Q4 | $19K | Hold |
12,941
| – | – | ﹤0.01% | 306 |
|
2021
Q3 | $38K | Hold |
12,941
| – | – | ﹤0.01% | 296 |
|
2021
Q2 | $43K | Hold |
12,941
| – | – | ﹤0.01% | 291 |
|
2021
Q1 | $49K | Hold |
12,941
| – | – | ﹤0.01% | 289 |
|
2020
Q4 | $46K | Hold |
12,941
| – | – | ﹤0.01% | 275 |
|
2020
Q3 | $85K | Hold |
12,941
| – | – | 0.01% | 263 |
|
2020
Q2 | $96K | Hold |
12,941
| – | – | 0.01% | 264 |
|
2020
Q1 | $61K | Sell |
12,941
-1
| -0% | -$5 | 0.01% | 272 |
|
2019
Q4 | $167K | Hold |
12,942
| – | – | 0.02% | 274 |
|
2019
Q3 | $136K | Hold |
12,942
| – | – | 0.01% | 285 |
|
2019
Q2 | $220K | Hold |
12,942
| – | – | 0.02% | 257 |
|
2019
Q1 | $436K | Buy |
+12,942
| New | +$436K | 0.04% | 171 |
|